HuagongsheHuagongshe Chemistry Print Report · For research reference only
Sodium Hydroxide → 2-[1,4]diazepan-1-yl-1-[2-(5-methyl-tetrazol-1-yl)-ethyl]-1H-benzoimidazole
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Sodium Hydroxide | HCID 14798 | — |
| Reactant | Hydrogen iodide | HCID 24841 | — |
| Reactant | 4-{1-[2-(5-methyl-tetrazol-1-yl)-ethyl]-1H-benzoimidazol-2-yl}-[1,4]diazepane-1-carboxylic acid tert-butyl ester | HCID 70147618 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | 2-[1,4]diazepan-1-yl-1-[2-(5-methyl-tetrazol-1-yl)-ethyl]-1H-benzoimidazole | HCID 18464466 | 84.4% |
Reaction Steps
Reflux 4-{1-[2-(5-methyl-tetrazol-1-yl)-ethyl]-1H-benzoimidazol-2-yl}-[1,4]diazepane-1-carboxylic acid tert-butyl ester (0.42 g, 0.98 mmol) in ethanol (15 mL) with 57% hydroiodic acid (5 mL) for one hour. Cool, treat with sodium hydroxide solution (final pH 13) and extract with dichloromethane (10×50 mL). Dry the combined organic phases (Na2SO4), filter and concentrate the filtrate in vacuo to afford 2-[1,4]diazepan-1-yl-1-[2-(5-methyl-tetrazol-1-yl)-ethyl]-1H-benzoimidazole (0.27 g), Rf=0.60 (silica gel, dichloromethane:methanol:ammonium hydroxide solution, 80:20:0.2).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US06423704B1 |
| Source dataset | uspto-grants-2002_07 |
| ORD ID | ord-c8f814e5d5724e3595efe880f4c1ff4e |
| Source note | uspto-grants-2002_07 |